Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510110815> ?p ?o ?g. }
- W2510110815 endingPage "3376" @default.
- W2510110815 startingPage "3358" @default.
- W2510110815 abstract "Ovarian cancer is a major cause of cancer mortality among women, largely due to late diagnosis of advanced metastatic disease. More extensive molecular analysis of metastatic ovarian cancer is needed to identify post-translational modifications of proteins, especially glycosylation that is particularly associated with metastatic disease to better understand the metastatic process and identify potential therapeutic targets. Glycoproteins in ascites fluid were enriched by affinity binding to lectins (ConA or WGA) and other affinity matrices. Separate glycomic, proteomic, and glycopeptide analyses were performed. Relative abundances of different N-glycan groups and proteins were identified from ascites fluids and a serum control. Levels of biomarkers CA125, MUC1, and fibronectin were also monitored in OC ascites samples by Western blot analysis. N-Glycan analysis of ascites fluids showed the presence of large, highly fucosylated and sialylated complex and hybrid glycans, some of which were not observed in normal serum. OC ascites glycoproteins, haptoglobin, fibronectin, lumican, fibulin, hemopexin, ceruloplasmin, alpha-1-antitrypsin, and alpha-1-antichymotrypsin were more abundant in OC ascites or not present in serum control samples. Further glycopeptide analysis of OC ascites identified N- and O-glycans in clusterin, hemopexin, and fibulin glycopeptides, some of which are unusual and may be important in OC metastasis." @default.
- W2510110815 created "2016-09-16" @default.
- W2510110815 creator A5001952491 @default.
- W2510110815 creator A5012301401 @default.
- W2510110815 creator A5049185721 @default.
- W2510110815 creator A5061231957 @default.
- W2510110815 creator A5073121510 @default.
- W2510110815 creator A5080379557 @default.
- W2510110815 creator A5084209996 @default.
- W2510110815 date "2016-08-23" @default.
- W2510110815 modified "2023-10-13" @default.
- W2510110815 title "Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides" @default.
- W2510110815 cites W1502053360 @default.
- W2510110815 cites W1532820434 @default.
- W2510110815 cites W1542488459 @default.
- W2510110815 cites W1578815789 @default.
- W2510110815 cites W1607584814 @default.
- W2510110815 cites W1965627327 @default.
- W2510110815 cites W1965646074 @default.
- W2510110815 cites W1967907911 @default.
- W2510110815 cites W1975303054 @default.
- W2510110815 cites W1976566500 @default.
- W2510110815 cites W1976985227 @default.
- W2510110815 cites W1977613111 @default.
- W2510110815 cites W1979467880 @default.
- W2510110815 cites W1980094415 @default.
- W2510110815 cites W1989015529 @default.
- W2510110815 cites W1989604922 @default.
- W2510110815 cites W1992383144 @default.
- W2510110815 cites W1993027982 @default.
- W2510110815 cites W1998504782 @default.
- W2510110815 cites W2006727249 @default.
- W2510110815 cites W2008545486 @default.
- W2510110815 cites W2009211019 @default.
- W2510110815 cites W2015556811 @default.
- W2510110815 cites W2016593129 @default.
- W2510110815 cites W2022832661 @default.
- W2510110815 cites W2024960751 @default.
- W2510110815 cites W2030068202 @default.
- W2510110815 cites W2031079181 @default.
- W2510110815 cites W2032387582 @default.
- W2510110815 cites W2035311426 @default.
- W2510110815 cites W2035813928 @default.
- W2510110815 cites W2043209609 @default.
- W2510110815 cites W2045289995 @default.
- W2510110815 cites W2048880738 @default.
- W2510110815 cites W2055222557 @default.
- W2510110815 cites W2061751482 @default.
- W2510110815 cites W2062302478 @default.
- W2510110815 cites W2065595227 @default.
- W2510110815 cites W2066781414 @default.
- W2510110815 cites W2071994095 @default.
- W2510110815 cites W2082047132 @default.
- W2510110815 cites W2085245237 @default.
- W2510110815 cites W2089755851 @default.
- W2510110815 cites W2090011301 @default.
- W2510110815 cites W2094719419 @default.
- W2510110815 cites W2095299242 @default.
- W2510110815 cites W2096116951 @default.
- W2510110815 cites W2096710540 @default.
- W2510110815 cites W2098373499 @default.
- W2510110815 cites W2104592689 @default.
- W2510110815 cites W2106875670 @default.
- W2510110815 cites W2112078820 @default.
- W2510110815 cites W2131043644 @default.
- W2510110815 cites W2134919151 @default.
- W2510110815 cites W2135581618 @default.
- W2510110815 cites W2142970078 @default.
- W2510110815 cites W2145479952 @default.
- W2510110815 cites W2146194407 @default.
- W2510110815 cites W2148671319 @default.
- W2510110815 cites W2149201762 @default.
- W2510110815 cites W2151998416 @default.
- W2510110815 cites W2161172528 @default.
- W2510110815 cites W2161817637 @default.
- W2510110815 cites W2162809593 @default.
- W2510110815 cites W2163905932 @default.
- W2510110815 cites W2299763846 @default.
- W2510110815 cites W2318280959 @default.
- W2510110815 cites W2328475808 @default.
- W2510110815 cites W2396771032 @default.
- W2510110815 cites W2415549051 @default.
- W2510110815 cites W2951081814 @default.
- W2510110815 cites W4206450623 @default.
- W2510110815 cites W4232168236 @default.
- W2510110815 doi "https://doi.org/10.1021/acs.jproteome.6b00548" @default.
- W2510110815 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5466807" @default.
- W2510110815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27500424" @default.
- W2510110815 hasPublicationYear "2016" @default.
- W2510110815 type Work @default.
- W2510110815 sameAs 2510110815 @default.
- W2510110815 citedByCount "25" @default.
- W2510110815 countsByYear W25101108152017 @default.
- W2510110815 countsByYear W25101108152018 @default.
- W2510110815 countsByYear W25101108152019 @default.
- W2510110815 countsByYear W25101108152020 @default.
- W2510110815 countsByYear W25101108152021 @default.
- W2510110815 countsByYear W25101108152022 @default.